机译:BMS-986242的发现和临床前评价,吲哚胺-2,3-二氧化酶1的有效选择性抑制剂1
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Biocon BMS R&
D Center Bommasandra Jigani Link Rd Bommasandra Industrial Area;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
Bristol Myers Squibb Research and Development;
indoleamine 2; 3-dioxygenase; IDO1; BMS-986242; immuno-oncology;
机译:发现羟基酰胺衍生物的高效性,选择性吲哚胺-2,3-二氧化根酶1抑制剂
机译:发现有效和口服的双环[1.1.1]戊烷衍生的吲哚胺-2,3-二氧化根酶1(IDO1)抑制剂
机译:发现咪唑异吲哚衍生物作为高效和口服活性吲哚胺-2,3-二氧化根酶抑制剂
机译:蛋白表位模拟方法:一种创新的选择性和高效丝氨酸蛋白酶抑制剂的方法
机译:临床前评估和有效的微管蛋白和Hsp27抑制剂作为抗癌药的鉴定。
机译:发现有效和选择性的ROMK抑制剂具有适合临床前评估的药代动力学特性
机译:发现有效和口服的双环1.1.1戊烷衍生的吲哚胺-2,3-二氧化根酶1(IDO1)抑制剂
机译:临床前测试有效和新型Bc1-2小分子抑制剂的治疗潜力,作为激素难治性前列腺癌的新疗法;最终的评论。 2004年11月30日至2007年11月29日